Order Article Reprints

Coghi P, Yang LJ, Ng JPL, Haynes RK, Memo M, Gianoncelli A, Wong VKW, Ribaudo G. A Drug Repurposing Approach for Antimalarials Interfering with SARS-CoV-2 Spike Protein Receptor Binding Domain (RBD) and Human Angiotensin-Converting Enzyme 2 (ACE2). Pharmaceuticals. 2021; 14(10):954. https://doi.org/10.3390/ph14100954

Coghi, Paolo, Li Jun Yang, Jerome P. L. Ng, Richard K. Haynes, Maurizio Memo, Alessandra Gianoncelli, Vincent Kam Wai Wong, and Giovanni Ribaudo. 2021. "A Drug Repurposing Approach for Antimalarials Interfering with SARS-CoV-2 Spike Protein Receptor Binding Domain (RBD) and Human Angiotensin-Converting Enzyme 2 (ACE2)" Pharmaceuticals 14, no. 10: 954. https://doi.org/10.3390/ph14100954

Coghi, P., Yang, L. J., Ng, J. P. L., Haynes, R. K., Memo, M., Gianoncelli, A., Wong, V. K. W., & Ribaudo, G. (2021). A Drug Repurposing Approach for Antimalarials Interfering with SARS-CoV-2 Spike Protein Receptor Binding Domain (RBD) and Human Angiotensin-Converting Enzyme 2 (ACE2). Pharmaceuticals, 14(10), 954. https://doi.org/10.3390/ph14100954